Raj Kumar Narang

1.9k total citations · 1 hit paper
66 papers, 1.4k citations indexed

About

Raj Kumar Narang is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Raj Kumar Narang has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 17 papers in Molecular Biology and 13 papers in Biomaterials. Recurrent topics in Raj Kumar Narang's work include Advanced Drug Delivery Systems (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Advancements in Transdermal Drug Delivery (9 papers). Raj Kumar Narang is often cited by papers focused on Advanced Drug Delivery Systems (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Advancements in Transdermal Drug Delivery (9 papers). Raj Kumar Narang collaborates with scholars based in India, Finland and Germany. Raj Kumar Narang's co-authors include Ravindra K. Rawal, Shelly Pathania, Ankita Dadwal, Ashish Baldi, Vineet Kumar, Tanmay S. Markandeywar, Shubham Sharma, Amit Sharma, Daisy Arora and Ghanshyam Das Gupta and has published in prestigious journals such as Life Sciences, European Journal of Medicinal Chemistry and Current Pharmaceutical Design.

In The Last Decade

Raj Kumar Narang

61 papers receiving 1.3k citations

Hit Papers

Role of sulphur-heterocycles in medicinal chemistry: An u... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raj Kumar Narang India 17 345 287 268 253 227 66 1.4k
Xinru Li China 28 263 0.8× 665 2.3× 582 2.2× 523 2.1× 329 1.4× 65 1.7k
Enam A. Khalil Jordan 25 188 0.5× 296 1.0× 297 1.1× 319 1.3× 357 1.6× 62 1.7k
Rudra Pangeni South Korea 19 82 0.2× 282 1.0× 324 1.2× 268 1.1× 170 0.7× 38 1.3k
Elvira Escribano Spain 21 162 0.5× 353 1.2× 309 1.2× 587 2.3× 302 1.3× 32 1.7k
Wenzhi Yang China 20 331 1.0× 434 1.5× 245 0.9× 220 0.9× 254 1.1× 42 1.2k
Mohammed Elmowafy Saudi Arabia 23 166 0.5× 390 1.4× 552 2.1× 821 3.2× 179 0.8× 61 1.9k
Maria Chiara Cristiano Italy 25 103 0.3× 320 1.1× 479 1.8× 494 2.0× 208 0.9× 57 1.5k
Mohammed Muqtader Ahmed Saudi Arabia 22 123 0.4× 238 0.8× 247 0.9× 436 1.7× 136 0.6× 81 1.1k
Ahmed S. Geneidi Egypt 24 165 0.5× 309 1.1× 295 1.1× 795 3.1× 127 0.6× 43 1.5k

Countries citing papers authored by Raj Kumar Narang

Since Specialization
Citations

This map shows the geographic impact of Raj Kumar Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj Kumar Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj Kumar Narang more than expected).

Fields of papers citing papers by Raj Kumar Narang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj Kumar Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj Kumar Narang. The network helps show where Raj Kumar Narang may publish in the future.

Co-authorship network of co-authors of Raj Kumar Narang

This figure shows the co-authorship network connecting the top 25 collaborators of Raj Kumar Narang. A scholar is included among the top collaborators of Raj Kumar Narang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raj Kumar Narang. Raj Kumar Narang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giri, Saroj Kumar, et al.. (2025). The expanding horizon of Oropouche virus: From epidemics to experimental gene therapy. Microbial Pathogenesis. 208. 107947–107947.
2.
Patel, Preeti, et al.. (2025). From resistance to Response: Metallic nanoparticles as game changers in triple negative breast cancer therapy. Journal of Drug Delivery Science and Technology. 113. 107322–107322.
4.
Narang, Raj Kumar, et al.. (2024). A comprehensive exploration of diverse green analytical techniques and their influence in different analytical fields. Separation Science Plus. 7(4). 17 indexed citations
5.
Patel, Preeti, et al.. (2024). Exploring metal-organic frameworks (MOFs) in drug delivery: A concise overview of synthesis approaches, versatile applications, and current challenges. Applied Materials Today. 41. 102443–102443. 30 indexed citations
6.
Narang, Raj Kumar, et al.. (2024). Recent advancements and applications of ophthalmic gene therapy strategies: A breakthrough in ocular therapeutics. Experimental Eye Research. 245. 109983–109983. 5 indexed citations
7.
Markandeywar, Tanmay S. & Raj Kumar Narang. (2024). Biosurfactant assisted synthesis and characterization of silver nanoparticles: In vitro investigation of their anti-oxidant, anti-inflammatory, anti-infective and wound healing potential. Inorganic Chemistry Communications. 165. 112506–112506. 3 indexed citations
8.
Shukla, Deeksha, et al.. (2024). Enhanced antichemobrain activity of amino acid assisted ferulic acid solid dispersion in adult zebrafish (Danio rerio). Drug Delivery and Translational Research. 14(12). 3422–3437.
9.
Singh, Gurmeet & Raj Kumar Narang. (2023). Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection. Assay and Drug Development Technologies. 22(1). 1–17.
10.
Narang, Raj Kumar, et al.. (2023). Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer’s Disease: Regulation of Nrf2 by Different Signaling Pathways. Current Molecular Medicine. 25(4). 372–387. 16 indexed citations
11.
Narang, Raj Kumar, et al.. (2023). Glabridin mitigates TiO2NP induced cognitive deficit in adult zebrafish. Neurochemistry International. 169. 105585–105585. 5 indexed citations
12.
Markandeywar, Tanmay S., Dilpreet Singh, & Raj Kumar Narang. (2023). A Critical Sojourn of Hyaluronic Acid-based Hydrogels in the Wound Healing Process: Current Advances and Future Prospects. Current Drug Therapy. 19(5). 561–593. 1 indexed citations
13.
Narang, Raj Kumar, et al.. (2023). Recent advancements in NS5B inhibitors (2011-2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure. 1293. 136272–136272. 2 indexed citations
14.
Singh, Amandeep, Uttam Kumar Mandal, & Raj Kumar Narang. (2021). Development and In Vivo Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and Saccharomyces boulardii for Management of Ulcerative Colitis. Assay and Drug Development Technologies. 20(1). 22–34. 3 indexed citations
15.
Sharma, Shubham, Vineet Kumar, Raj Kumar Narang, & Tanmay S. Markandeywar. (2021). Collagen-based formulations for wound healing: A literature review. Life Sciences. 290. 120096–120096. 141 indexed citations
16.
17.
Dadwal, Ankita, Neeraj Mishra, & Raj Kumar Narang. (2020). Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-Based Gel for the Treatment of Plaque Psoriasis. Current Molecular Pharmacology. 14(3). 399–411. 6 indexed citations
18.
Singh, Amandeep, et al.. (2019). Novel approaches for ocular drug delivery: A review. 8(7). 2722–2735. 2 indexed citations
19.
Bhardwaj, Ankur, Lalit Kumar, Raj Kumar Narang, & R. S. R. Murthy. (2012). Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis. Artificial Cells Nanomedicine and Biotechnology. 41(1). 52–59. 34 indexed citations
20.
Narang, Raj Kumar, et al.. (2011). Advances in Pulmonary Delivery of Nanoparticles. Artificial Cells Blood Substitutes and Biotechnology. 40(1-2). 75–96. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026